Literature DB >> 31772963

Anteriorly Oriented Beam Arrangements with Daily in Vivo Range Verification for Proton Therapy of Prostate Cancer: Rectal Toxicity Rates.

Jerimy C Polf1, Michael Chuong1, Bin Zhang1, Minesh Mehta1.   

Abstract

PURPOSE: To model whether in vivo range verification could reduce high-grade rectal toxicity for patients with prostate cancer treated with pencil beam scanning proton therapy by allowing novel proton beam arrangements compared to standard lateral opposed beams.
MATERIALS AND METHODS: Proton plans were generated for 8 patients with prostate cancer previously treated with photons by volumetric-modulated arc therapy (VMAT). The VMAT plans were generated by using a uniform 6-mm planning target volume (PTV) expansion. For the proton plans an additional distal margin (3.5% of beam range) was added to the uniform 6-mm PTV to account for range uncertainty, using 3 beam arrangements: (1) lateral opposed beams (LAT), (2) left and right anterior oblique beams (LAO/RAO), and (3) a single anterior-posterior beam (AP). Assuming use of in vivo range verification, plans were generated by using a reduced distal PTV and distal range uncertainty expansion (2 mm each) with AP (AP-2 mm) and LAO/RAO (LAO/RAO-2 mm) beam arrangements. Estimates of normal tissue complication probability (NTCP) for ≥grade 2 rectal bleeding were generated by using the Lyman-Kutcher-Burman model.
RESULTS: Each proton and photon plan was able to achieve all prespecified rectal and bladder constraints. For the VMAT, LAT, AP, and LAO/RAO plans, estimated NTCP values for ≥grade 2 rectal bleeding were 0.19, 0.21, 0.24, and 0.2, respectively. For the AP-2 mm and LAO/RAO-2 mm plans, NTCP values were reduced to 0.11 and 0.1 with respect to ≥grade 2 rectal bleeding.
CONCLUSION: Presuming that in vivo range verification for pencil beam scanning proton therapy could localize the distal falloff of the Bragg peak to within 2 mm, novel beam arrangements (AP and LAO/RAO) may reduce the risk of serious rectal bleeding, compared to VMAT and LAT proton treatment techniques. These are achieved without an increase in modeled bladder complication rates. © Copyright 2016 International Journal of Particle Therapy.

Entities:  

Year:  2016        PMID: 31772963      PMCID: PMC6871638          DOI: 10.14338/IJPT-15-00015.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  20 in total

1.  Imaging of prompt gamma rays emitted during delivery of clinical proton beams with a Compton camera: feasibility studies for range verification.

Authors:  Jerimy C Polf; Stephen Avery; Dennis S Mackin; Sam Beddar
Journal:  Phys Med Biol       Date:  2015-08-28       Impact factor: 3.609

2.  Dosimetric accuracy of planning and delivering small proton therapy fields.

Authors:  Bryan Bednarz; Juliane Daartz; Harald Paganetti
Journal:  Phys Med Biol       Date:  2010-11-19       Impact factor: 3.609

3.  Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer.

Authors:  Sujay A Vora; William W Wong; Steven E Schild; Gary A Ezzell; Michele Y Halyard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

4.  Prompt gamma imaging of proton pencil beams at clinical dose rate.

Authors:  I Perali; A Celani; L Bombelli; C Fiorini; F Camera; E Clementel; S Henrotin; G Janssens; D Prieels; F Roellinghoff; J Smeets; F Stichelbaut; F Vander Stappen
Journal:  Phys Med Biol       Date:  2014-09-10       Impact factor: 3.609

5.  Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.

Authors:  M Moteabbed; S España; H Paganetti
Journal:  Phys Med Biol       Date:  2011-01-25       Impact factor: 3.609

6.  Multi-institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.

Authors:  Keiji Nihei; Takashi Ogino; Masakatsu Onozawa; Shigeyuki Murayama; Hiroshi Fuji; Masao Murakami; Yoshio Hishikawa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-09       Impact factor: 7.038

7.  Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.

Authors:  Rovel J Colaco; Bradford S Hoppe; Stella Flampouri; Brian T McKibben; Randal H Henderson; Curtis Bryant; Romaine C Nichols; William M Mendenhall; Zuofeng Li; Zhong Su; Christopher G Morris; Nancy P Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-11-05       Impact factor: 7.038

8.  Anterior-oriented proton beams for prostate cancer: A multi-institutional experience.

Authors:  John J Cuaron; Alexander A Harris; Brian Chon; Henry Tsai; Gary Larson; William F Hartsell; Eugen Hug; Oren Cahlon
Journal:  Acta Oncol       Date:  2015-01-16       Impact factor: 4.089

9.  Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?

Authors:  Deborah A Kuban; Lawrence B Levy; M Rex Cheung; Andrew K Lee; Seungtaek Choi; Steven Frank; Alan Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-20       Impact factor: 7.038

10.  Improved beam angle arrangement in intensity modulated proton therapy treatment planning for localized prostate cancer.

Authors:  Wenhua Cao; Gino J Lim; Yupeng Li; X Ronald Zhu; Xiaodong Zhang
Journal:  Cancers (Basel)       Date:  2015-03-30       Impact factor: 6.639

View more
  1 in total

Review 1.  Proton Therapy for Prostate Cancer: Challenges and Opportunities.

Authors:  Darren M C Poon; Stephen Wu; Leon Ho; Kin Yin Cheung; Ben Yu
Journal:  Cancers (Basel)       Date:  2022-02-13       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.